CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients-Reference-Cited by-同舟云学术

CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients

Published:2011-05-02 Issue:5 Volume:121 Page:1822-1826
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Savoldo Barbara,Ramos Carlos Almeida,Liu Enli,Mims Martha P.,Keating Michael J.,Carrum George,Kamble Rammurti T.,Bollard Catherine M.,Gee Adrian P.,Mei Zhuyong,Liu Hao,Grilley Bambi,Rooney Cliona M.,Heslop Helen E.,Brenner Malcolm K.,Dotti Gianpietro

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference25 articles.

1. Adoptive cell transfer: a clinical path to effective cancer immunotherapy

2. Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

3. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

4. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.

5. The promise and potential pitfalls of chimeric antigen receptors

Cited by 867 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of anti-TIM3 chimeric antigen receptor with CD8α spacer and TNFR-based costimulation for enhanced efficacy in AML therapy;Biomedicine & Pharmacotherapy;2024-10

2. The rules of T-cell engagement: current state of CAR T cells and bispecific antibodies in B-cell lymphomas;Blood Advances;2024-09-10

3. Chimeric antigen receptor T-cell therapy in acute myeloid leukaemia: Novel therapeutic approaches to longstanding challenges;Gene Reports;2024-09

4. Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder;Experimental Hematology & Oncology;2024-08-19

5. CHIMERIC ANTIGEN RECEPTOR T CELLS: PAST, PRESENT, AND FUTURE;Asian Journal of Pharmaceutical and Clinical Research;2024-07-07